Conference Information


13th Annual Proteins and Antibodies Congress


13th Annual Proteins and Antibodies Congress, London, United Kingdom
Conference Title
13th Annual Proteins and Antibodies Congress
Event Type
Conference
Conference Date
27-04-2020 to 29-04-2020
Location
London, United Kingdom

Organization Name / Organize By
Oxford Global
Organizing/Related Departments
Oxford Global
Organization Type
Event Organizing Company
Conference Category
Both (Technical & Non Technical)
Conference Level
International
Related Industries

Medical/Healthcare/Hospital

Location
London, United Kingdom

Over 80 case studies, presentations, panel debates and roundtable discussions focused on the key issues in protein and antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production and manufacturing.

View Agenda: https://bit.ly/2MU7dBq

27 April 2019 – Day One (Kick-Off Sessions)
• Protein Engineering, Expression, Design and Selection
• Bioanalysis: Characterisation, Stability Testing And Formulation Development
• Biotherapeutics: Discovery and Development – Oncology and Immuno-Oncology

28 April 2020 – Day Two
• Antibody Engineering, Screening, Design, Development
• ADC Engineering, Bioconjugates and Fusion Proteins
• Biotherapeutics: Discovery and Development – Oncology and Immuno-Oncology

29 April 2020 – Day Three
• Antibody Engineering, Development and Generation (Part 1) and Biotherapeutics: Discovery and Development–Non-Oncology Indications (Part 2)
• Bioanalysis: PKPD and Manufacturing
• Biotherapeutics: Discovery and Development – Non-Oncology Indications

PLUS:
• Roundtable and Panel Discussions
• Pre-Event Webinars

Others Details

Time: 8:00 am - 6:00 pm Speakers: Tristan Vaughan, Vice President R&D, Antibody Discovery and Protein Engineering, AstraZeneca, Stanislas Blein, Vice President, Head of Antibody Engineering, Glenmark Pharmaceuticals, John McCafferty, Chief Executive Officer, IONTAS Pharmaceuticals, Mahendra Deonarain, Chief Executive and Science Officer, Antikor Biopharma, Andrew Porter, Chief Technology Officer and Professor of Medical Biotechnology, Elasmogen and University of Aberdeen

Registration Fees
Available
Registration Fees Details
General Admission: GBP 520.00
Registration Ways
Other
Address/Venue
Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith  Pin/Zip Code : W6 8DR
Contact
Danielle Dalby

[email protected]

     +441865248455